Intraoperative three-dimensional fabrication of living tissues could be the next biomedical revolution in patient treatment.
We developed a surgery-ready robotic three-dimensional bioprinter and demonstrated that a bioprinting procedure using medical grade hydrogel could be performed using a 6-axis robotic arm in vivo for treating burn injuries.
We conducted a pilot swine animal study on a deep third-degree severe burn model. We observed that the use of cell-laden bioink as treatment substantially affects skin regeneration, producing in situ fibroblast growth factor and vascular endothelial growth factor, necessary for tissue regeneration and re-epidermalization of the wound.
We described an animal study of intraoperative three-dimensional bioprinting living tissue. This emerging technology brings the first proof of in vivo skin printing feasibility using a surgery-ready robotic arm-based bioprinter. Our positive outcome in skin regeneration, joined with this procedure’s feasibility, allow us to envision the possibility of using this innovative approach in a human clinical trial in the near future.
By Albouy Marion ,Desanlis Adeline, Brosset Sophie ,Auxenfans Celine, Courtial Edwin-Joffrey, Eli Kyle, Palmer Justin, Vidal Luciano, Thépot Amélie, Dos Santos Morgan, Christophe A- January 2022
Beatrice Wihlander 11 June 2025 Givaudan is showcasing its fragrance technologies, which are underscored by…
After over 10 years of testing sunscreen products, at Zurko Research we are proud to…
Mack Degueurin 22 April 2025 The wearable device analyzes the tiny changes in physical responses…